| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13550a2e931b7820247a58278354ee62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99505f5f312672820e9f78c254c00a4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d373ea1ecd334fb2bf06463dfa2a481f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-665 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2009-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a0620e70c8feb98fb0838ab54bb5934
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bade4bff37f09ff1300f9a930a48b84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da68e68aaebf3442dc89b0455df1b551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_904bb0aeb94fefdbbd3858e832a9c869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_674aae5292d1280376df49b1fc8771b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8d8f851ea126801ffbdd7f5320dd3fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31773a488d78a378fc22629e0732355f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc96fc34e4ba413d0185c4d1d0c11359 |
| publicationDate |
2011-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011178013-A1 |
| titleOfInvention |
Novel octapeptide compounds derived from somatostatin and the therapeutic use thereof |
| abstract |
The present invention relates to novel octapeptide compounds of general formula (I): H-2-Nal 1 -cyclo(Cys 2 -Tyr 3 -AA 4 -Lys 5 -Val 6 -Cys 7 )-Thr 8 -NH 2 . Since these products have a good affinity for certain somatostatin receptor subtypes, they are particularly advantageous for treating pathological states or diseases in which one (or more) somatostatin receptor(s) is (are) involved. These compounds furthermore have physiochemical properties that make it possible to envisage them in diverse solutions for the formulation of medicaments, for example as a pharmaceutically acceptable carrier. The invention also relates to pharmaceutical compositions containing said products and to the use thereof for the preparation of a medicament. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8952128-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112703008-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9603942-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10206968-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020018315-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9352012-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9777039-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10543249-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510961-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279732-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9731027-B2 |
| priorityDate |
2008-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |